Friday, February 23, 2018 2:31:10 AM
SHMN - What You Can Expect To Happen!
SHMN - Target $0.01 By March 1, 2018
SHMN - Crossing Primary Squeeze Trigger Price
Shorts getting Squeezed - Covering Short Positions
BuyIns.Net Alerts
•[01/19/2018 12:35 PST] SHMN SqueezeTrigger
Short Sellers Still Need To Cover
http://www.buyins.net/tools/symbol_stats.php?sym=SHMN
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=137825853
________________________________________________________________
https://twitter.com/sohminc
http://www.sohm.com/
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=138599583
SHMN - Target $0.01 By March 1, 2018
SHMN - Crossing Primary Squeeze Trigger Price
Shorts getting Squeezed - Covering Short Positions
BuyIns.Net Alerts
•[01/19/2018 12:35 PST] SHMN SqueezeTrigger
Short Sellers Still Need To Cover
http://www.buyins.net/tools/symbol_stats.php?sym=SHMN
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=137825853
________________________________________________________________
In reference to lot of calls and inquiry about current status at OTC, company would like to state that: "The company is working with its legal counsel and accountants to bring the company current with OTC as quickly as it possibly can."
— SOHM, Inc. (@sohminc) February 15, 2018
https://twitter.com/sohminc
http://www.sohm.com/
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=138599583
Recent SHMN News
- SOHM Inc. Releases White Paper on ABBIE, a Cas9-Guided Integrase Enabling Stable Gene Integration and Creation of SKOV3-GYS1 Cell Line for Drug Discovery • ACCESS Newswire • 11/06/2025 02:30:00 PM
- SOHM Notes FDA's Evolving Gene-Editing Framework in Context of Ongoing ABBIE Platform Development • ACCESS Newswire • 11/04/2025 02:30:00 PM

